Delivery Order SPE2DB20D3103-SPE2DB24FM8J3

Award Date 2/27/24
Potential Completion Date 3/19/24
Potential Value $92K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,782.51 firm fixed-price delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has an ultimate completion date of April 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 that serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $149,698.80 firm fixed-price delivery order is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML medical products. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,823.40 Firm Fixed Price Delivery Order covers the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 26, 2024 and was awarded on December 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,906.79 firm fixed-price delivery order contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,823.40 Firm Fixed Price Delivery Order is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,875.72 delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has a firm fixed price. The contract has an ultimate completion date of February 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is a delivery order worth $47,470.20 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has an ultimate completion date of December 23, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,966.77 firm fixed price delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract has a period of performance through March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,875.72 Firm Fixed Price Delivery Order contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML pharmaceutical products. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,906.79, is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM8J3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,768.80 firm fixed-price delivery order (SPE2DB20D3103) covers the supply of the prescription drug OPDIVO 240 MG/24 ML VIAL 24ML, with a period of performance through March 19, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award did not have a specific set-aside designation, indicating open competition.

Generated 2/27/25, 12:32 PM